In this study, we aim to explore the effect of the combination of PRMT5 inhibitor (AMI-1) and cisplatin on cell viability in an in vitro lung cancer model, compared with normal bronchial epithelial cells. The gene discussed is PRMT5; the disease is lung carcinoma.